(Q35679885)

9 August 2017

1 reference

title

Immunophenotyping of acute leukemias and myelodysplastic syndromes (English)

1 reference

9 August 2017

Alberto Orfao

1

1 reference

9 August 2017

Francisco Ortuño

2

1 reference

9 August 2017

Maria de Santiago

3

1 reference

9 August 2017

Antonio Lopez

4

1 reference

9 August 2017

Jesus San Miguel

5

1 reference

9 August 2017

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

58

1 reference

9 August 2017

1

1 reference

9 August 2017

62-71

1 reference

Clinical applications of laser scanning cytometry

9 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Flow cytometry in the diagnosis of acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Minimal residual disease in leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Determination of minimal residual disease in leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Monoclonal antibody therapies in leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Expression of human T and B lymphocyte cell-surface markers on leukaemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Acute lymphoblastic leukaemia in children: Classification and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Myelodysplastic syndrome: a search for minimal diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Immunophenotypic clustering of myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Clinical and biologic features of CD4+CD56+ malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

Phenotypic heterogeneity and cellular origins of T cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: a multiparameter analysis of 300 cases

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Immunologic monitoring in adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Myeloid-antigen expression in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Immunological classification of acute myeloblastic leukemias: relevance to patient outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Characterization of aberrant phenotypes in acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Immunophenotype of hematologic neoplasms with a translocation t(8;21).

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.10104

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.10104

1 reference

9 August 2017

1 reference